208 related articles for article (PubMed ID: 14665948)
1. Germline mutation analysis of the androgen receptor gene in Finnish patients with prostate cancer.
Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
J Urol; 2004 Jan; 171(1):431-3. PubMed ID: 14665948
[TBL] [Abstract][Full Text] [Related]
2. Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.
Mononen N; Syrjäkoski K; Matikainen M; Tammela TL; Schleutker J; Kallioniemi OP; Trapman J; Koivisto PA
Cancer Res; 2000 Nov; 60(22):6479-81. PubMed ID: 11103816
[TBL] [Abstract][Full Text] [Related]
3. R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.
Gruber SB; Chen H; Tomsho LP; Lee N; Perrone EE; Cooney KA
Prostate; 2003 Mar; 54(4):306-9. PubMed ID: 12539229
[TBL] [Abstract][Full Text] [Related]
4. Identification of two germline point mutations in the 5'UTR of the androgen receptor gene in men with prostate cancer.
Crocitto LE; Henderson BE; Coetzee GA
J Urol; 1997 Oct; 158(4):1599-601. PubMed ID: 9302181
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.
Taplin ME; Bubley GJ; Shuster TD; Frantz ME; Spooner AE; Ogata GK; Keer HN; Balk SP
N Engl J Med; 1995 May; 332(21):1393-8. PubMed ID: 7723794
[TBL] [Abstract][Full Text] [Related]
6. Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer.
Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
J Urol; 2004 Aug; 172(2):506-7. PubMed ID: 15247715
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics.
Chen G; Wang X; Zhang S; Lu Y; Sun Y; Zhang J; Li Z; Lu J
Prostate; 2005 Jun; 63(4):395-406. PubMed ID: 15617028
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor gene mutations in hormone-refractory prostate cancer.
Wallén MJ; Linja M; Kaartinen K; Schleutker J; Visakorpi T
J Pathol; 1999 Dec; 189(4):559-63. PubMed ID: 10629558
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
Tilley WD; Buchanan G; Hickey TE; Bentel JM
Clin Cancer Res; 1996 Feb; 2(2):277-85. PubMed ID: 9816170
[TBL] [Abstract][Full Text] [Related]
10. Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.
Waltering KK; Wallén MJ; Tammela TL; Vessella RL; Visakorpi T
Prostate; 2006 Nov; 66(15):1585-91. PubMed ID: 16927275
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR.
Engehausen DG; Krause FS; Fleischmann J; Akcetin Z; Schrott KM; Endele S
Anticancer Res; 2005; 25(3A):1611-4. PubMed ID: 16033069
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis.
Evans BA; Harper ME; Daniells CE; Watts CE; Matenhelia S; Green J; Griffiths K
Prostate; 1996 Mar; 28(3):162-71. PubMed ID: 8628719
[TBL] [Abstract][Full Text] [Related]
13. The androgen receptor gene and its influence on the development and progression of prostate cancer.
Montgomery JS; Price DK; Figg WD
J Pathol; 2001 Sep; 195(2):138-46. PubMed ID: 11592091
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor mutations in prostate cancer.
Marcelli M; Ittmann M; Mariani S; Sutherland R; Nigam R; Murthy L; Zhao Y; DiConcini D; Puxeddu E; Esen A; Eastham J; Weigel NL; Lamb DJ
Cancer Res; 2000 Feb; 60(4):944-9. PubMed ID: 10706109
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the BRG1 gene in prostate cancer clinical samples.
Valdman A; Nordenskjöld A; Fang X; Naito A; Al-Shukri S; Larsson C; Ekman P; Li C
Int J Oncol; 2003 May; 22(5):1003-7. PubMed ID: 12684665
[TBL] [Abstract][Full Text] [Related]
16. Germline ATBF1 mutations and prostate cancer risk.
Xu J; Sauvageot J; Ewing CM; Sun J; Liu W; Isaacs SD; Wiley KE; Diaz L; Zheng SL; Walsh PC; Isaacs WB
Prostate; 2006 Jul; 66(10):1082-5. PubMed ID: 16637072
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations of the MSR1 gene in prostate cancer families from Germany.
Maier C; Vesovic Z; Bachmann N; Herkommer K; Braun AK; Surowy HM; Assum G; Paiss T; Vogel W
Hum Mutat; 2006 Jan; 27(1):98-102. PubMed ID: 16287155
[TBL] [Abstract][Full Text] [Related]
18. Studies on androgen receptor mutations and amplification in human prostate cancer.
Culig Z; Hobisch A; Erdel M; Bartsch G; Klocker H
Methods Mol Med; 2003; 81():267-75. PubMed ID: 12725126
[No Abstract] [Full Text] [Related]
19. Androgen receptor in prostate cancer: cause or cure?
Bevan CL
Trends Endocrinol Metab; 2005 Nov; 16(9):395-7. PubMed ID: 16202619
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic functional properties of androgen receptor mutants in prostate cancer.
Bergerat JP; Céraline J
Hum Mutat; 2009 Feb; 30(2):145-57. PubMed ID: 18800375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
